BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Soumit Roy does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 TARAProtara Therapeutics Inc | Buy | $21.00 | May 2025 | +40.1% | Miss |
 AVBPArriVent BioPharma, Inc. Common Stock | Buy | $40.00 | May 2025 | +19.2% | Miss |
 ELVNEnliven Therapeutics Inc. | Buy | $27.00 | May 2025 | +124.8% | Hit |
 BEAMBeam Therapeutics Inc | Buy | $34.00 | Mar 2025 | −8.0% | Hit |
 INABIn8bio Inc | Buy | $1.20 | Feb 2025 | −86.2% | Miss |
 OKUROnKure Therapeutics, Inc. | Buy | $32.00 | Jan 2025 | −54.2% | Miss |
| ELVNEnliven Therapeutics Inc. | Buy | $36.00 | Oct 2024 | −14.6% | Miss |
 ELTXElicio Therapeutics Inc. | Buy | $9.00 | Oct 2024 | +103.0% | Hit |
 EDITEditas Medicine Inc | Buy | $13.00 | Sep 2024 | −19.7% | Miss |
 ACETAdicet Bio Inc | Buy | $4.00 | Sep 2024 | −33.5% | Miss |
| INABIn8bio Inc | Buy | $6.50 | Jun 2024 | −87.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.